Comparison of generic and lung cancer-specific quality of life instruments for predictive ability of survival in patients with advanced lung cancer

Eser S., GÖKSEL T., Erbaycu A. E., BAYDUR H., Basarik B., Yanik A. O., ...Daha Fazla

SPRINGERPLUS, cilt.5, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 5
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1186/s40064-016-3492-7
  • Dergi Adı: SPRINGERPLUS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Lung cancer, HRQOL, Prognostic factors, Survival, COOPERATIVE-ONCOLOGY-GROUP, PROGNOSTIC-FACTORS, EUROPEAN-ORGANIZATION, CLINICAL-TRIALS, EORTC QLQ-C30, RECEIVING CHEMOTHERAPY, FUNCTIONAL ASSESSMENT, PERFORMANCE STATUS, REPORTED HEALTH, QUESTIONNAIRE
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: Our purpose is to examine the relationship of Health related quality of life measured by EORTC QLQc30, QLQ-LC13; FACT-L, LCSS, Eq5D) with survival in advanced lung cancer patients. A total of 299 Lung Cancer (LC) patients were, included in this national multicenter Project entitled of "the LC Quality of Life Project (AKAYAK). Baseline scores were analyzed by using Cox's proportional hazard regression to identify factors that influenced survival. Univariate and multivariate models were run for each of the scales included in the study.